IN2014DN06989A - - Google Patents

Info

Publication number: IN2014DN06989A
Authority: IN; India
Prior art keywords: eosinophilic; alkyl; macular degeneration; related macular; age related
Prior art date: 2012-04-03

Application number

Other languages

English (en)

Inventor

Michael Chadham Nivens

Thierry Bouyssou

Rolf Goeggel

Peter Seither

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-04-03

Filing date

2013-04-02

Publication date

2015-04-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48040249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN06989(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-04-02 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2015-04-10 Publication of IN2014DN06989A publication Critical patent/IN2014DN06989A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Structure Of Transmissions (AREA)

IN6989DEN2014 2012-04-03 2013-04-02 IN2014DN06989A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12162937		2012-04-03
PCT/EP2013/056864 WO2013149986A1 (en)	2012-04-03	2013-04-02	Use of ccr3-inhibitors

Publications (1)

Publication Number	Publication Date
IN2014DN06989A true IN2014DN06989A (es)	2015-04-10

Family

ID=48040249

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN6989DEN2014 IN2014DN06989A (es)	2012-04-03	2013-04-02

Country Status (27)

Country	Link
US (5)	US20130261153A1 (es)
EP (3)	EP2833884B1 (es)
JP (2)	JP2015512432A (es)
KR (4)	KR20200044988A (es)
CN (2)	CN104220073A (es)
AU (1)	AU2013245027B2 (es)
BR (1)	BR112014023795B1 (es)
CA (1)	CA2869269C (es)
CL (1)	CL2014002523A1 (es)
CY (1)	CY1123222T1 (es)
DK (1)	DK2833884T3 (es)
EA (1)	EA032263B1 (es)
ES (1)	ES2811554T3 (es)
HR (1)	HRP20201165T1 (es)
HU (1)	HUE051648T2 (es)
IL (1)	IL234262A (es)
IN (1)	IN2014DN06989A (es)
LT (1)	LT2833884T (es)
MX (1)	MX2014011786A (es)
NZ (1)	NZ628882A (es)
PH (1)	PH12014502239A1 (es)
PL (1)	PL2833884T3 (es)
PT (1)	PT2833884T (es)
RS (1)	RS60665B1 (es)
SI (1)	SI2833884T1 (es)
WO (1)	WO2013149986A1 (es)
ZA (1)	ZA201406082B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8278302B2 (en)	2009-04-08	2012-10-02	Boehringer Ingelheim International Gmbh	Substituted piperidines as CCR3 antagonists
UA109290C2 (uk)	2010-10-07	2015-08-10		Спільні кристали і солі інгібіторів ccr3
US8680280B2 (en)	2012-04-02	2014-03-25	Boehringer Ingelheim International Gmbh	Process for the manufacturing of CRR inhibitors
US20130261153A1 (en) *	2012-04-03	2013-10-03	Boehringer Ingelheim International Gmbh	Use of ccr3-inhibitors
US10213421B2 (en)	2012-04-04	2019-02-26	Alkahest, Inc.	Pharmaceutical formulations comprising CCR3 antagonists
US11045284B2 (en)	2016-11-24	2021-06-29	Kirishima Seiko Co., Ltd.	Dental brace and method for attaching dental brace
CA3058654A1 (en) *	2017-04-05	2018-10-11	Alkahest Inc.	Methods and compositions for treating retina-associated disease using ccr3-inhibitors
BR112019020798A2 (pt) *	2017-04-05	2020-04-28	Alkahest Inc	métodos e composições para tratamento de danos associados ao envelhecimento usando inibidores de ccr3
SG11202002437VA (en) *	2017-10-13	2020-04-29	Alkahest Inc	Methods and compositions for treating pruritus, xerosis, and associated disease using ccr3-inhibitors
MX2020011114A (es)	2018-05-15	2021-01-29	Alkahest Inc	Tratamiento de enfermedades asociadas con el envejecimiento con moduladores de la leucotrieno a4 hidrolasa.
MX2021002967A (es) *	2018-09-26	2021-08-11	Alkahest Inc	Metodos y composiciones para tratar deterioros asociados con el envejecimiento usando inhibidores ccr3.
CN115697334A (zh) *	2020-06-11	2023-02-03	万能溶剂有限公司	使用ccr3抑制剂改善视网膜相关疾病结果的方法
WO2023076679A1 (en)	2021-11-01	2023-05-04	Alkahest, Inc.	Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6339087B1 (en) *	1997-08-18	2002-01-15	Syntex (U.S.A.) Llc	Cyclic amine derivatives-CCR-3 receptor antagonists
WO2001066754A1 (en) *	2000-03-03	2001-09-13	Cambridge Antibody Technology Limited	Human antibodies against eotaxin and their use
US20020151064A1 (en) *	2001-02-07	2002-10-17	Children's Hospital Medical Center	Regulation of CCR3 expression
WO2006083390A2 (en) *	2004-12-07	2006-08-10	Children's Hospital Medical Center	Eotaxin-3 in eosinophilic esophagitis
US8008092B2 (en) *	2007-10-09	2011-08-30	University Of Kentucky Research Foundation	CCR3 inhibition for ocular angiogenesis and macular degeneration
WO2010069979A1 (en) *	2008-12-16	2010-06-24	Nycomed Gmbh	Pyran derivatives as ccr3 modulators
EP2236520A1 (en) *	2009-03-31	2010-10-06	Leukocare Ag	Stabilizing composition for immobilized biomolecules
US8278302B2 (en) *	2009-04-08	2012-10-02	Boehringer Ingelheim International Gmbh	Substituted piperidines as CCR3 antagonists
US8778616B2 (en) *	2009-05-26	2014-07-15	University Of Kentucky Research Foundation	Method of using CCR3 binding agents to detect choroidal neovascularization
UA109290C2 (uk) *	2010-10-07	2015-08-10		Спільні кристали і солі інгібіторів ccr3
US20130261153A1 (en) *	2012-04-03	2013-10-03	Boehringer Ingelheim International Gmbh	Use of ccr3-inhibitors
US10213421B2 (en) *	2012-04-04	2019-02-26	Alkahest, Inc.	Pharmaceutical formulations comprising CCR3 antagonists
WO2020115836A1 (ja) *	2018-12-05	2020-06-11	東浜工業株式会社	ブロワー装置

2013
- 2013-03-27 US US13/851,564 patent/US20130261153A1/en not_active Abandoned
- 2013-04-02 ES ES13713199T patent/ES2811554T3/es active Active
- 2013-04-02 KR KR1020207011392A patent/KR20200044988A/ko active Application Filing
- 2013-04-02 BR BR112014023795-6A patent/BR112014023795B1/pt active IP Right Grant
- 2013-04-02 MX MX2014011786A patent/MX2014011786A/es unknown
- 2013-04-02 CA CA2869269A patent/CA2869269C/en active Active
- 2013-04-02 SI SI201331753T patent/SI2833884T1/sl unknown
- 2013-04-02 LT LTEP13713199.1T patent/LT2833884T/lt unknown
- 2013-04-02 HU HUE13713199A patent/HUE051648T2/hu unknown
- 2013-04-02 DK DK13713199.1T patent/DK2833884T3/da active
- 2013-04-02 RS RS20200868A patent/RS60665B1/sr unknown
- 2013-04-02 PT PT137131991T patent/PT2833884T/pt unknown
- 2013-04-02 KR KR1020147027679A patent/KR20140144200A/ko active Application Filing
- 2013-04-02 EP EP13713199.1A patent/EP2833884B1/en active Active
- 2013-04-02 IN IN6989DEN2014 patent/IN2014DN06989A/en unknown
- 2013-04-02 EA EA201401083A patent/EA032263B1/ru unknown
- 2013-04-02 NZ NZ628882A patent/NZ628882A/en unknown
- 2013-04-02 AU AU2013245027A patent/AU2013245027B2/en active Active
- 2013-04-02 WO PCT/EP2013/056864 patent/WO2013149986A1/en active Application Filing
- 2013-04-02 KR KR1020227031439A patent/KR20220132012A/ko not_active Application Discontinuation
- 2013-04-02 CN CN201380016333.7A patent/CN104220073A/zh active Pending
- 2013-04-02 JP JP2015503847A patent/JP2015512432A/ja active Pending
- 2013-04-02 EP EP20174399.4A patent/EP3763369B1/en active Active
- 2013-04-02 PL PL13713199T patent/PL2833884T3/pl unknown
- 2013-04-02 KR KR1020217015686A patent/KR20210063481A/ko not_active IP Right Cessation
- 2013-04-02 CN CN201910406245.7A patent/CN110384699A/zh active Pending
- 2013-04-02 EP EP24158785.6A patent/EP4389217A3/en active Pending
2014
- 2014-08-19 ZA ZA2014/06082A patent/ZA201406082B/en unknown
- 2014-08-24 IL IL234262A patent/IL234262A/en active IP Right Grant
- 2014-09-24 CL CL2014002523A patent/CL2014002523A1/es unknown
- 2014-10-03 PH PH12014502239A patent/PH12014502239A1/en unknown
- 2014-12-15 US US14/570,298 patent/US20150099783A1/en not_active Abandoned
2015
- 2015-11-30 US US14/953,480 patent/US20160081998A1/en not_active Abandoned
2017
- 2017-07-25 US US15/658,918 patent/US20170319567A1/en not_active Abandoned
- 2017-12-22 JP JP2017246173A patent/JP2018080183A/ja not_active Withdrawn
2020
- 2020-07-23 CY CY20201100678T patent/CY1123222T1/el unknown
- 2020-07-27 HR HRP20201165TT patent/HRP20201165T1/hr unknown
- 2020-08-19 US US16/997,772 patent/US20200375971A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP2833884B1 (en)	2020-05-20
CA2869269C (en)	2020-06-30
LT2833884T (lt)	2020-09-10
PL2833884T3 (pl)	2020-11-02
US20170319567A1 (en)	2017-11-09
KR20200044988A (ko)	2020-04-29
IL234262A (en)	2017-10-31
EP3763369A1 (en)	2021-01-13
US20200375971A1 (en)	2020-12-03
EP2833884A1 (en)	2015-02-11
BR112014023795A2 (es)	2017-06-20
CN104220073A (zh)	2014-12-17
EP4389217A3 (en)	2024-08-28
NZ628882A (en)	2016-05-27
EP3763369B1 (en)	2024-02-28
ES2811554T3 (es)	2021-03-12
AU2013245027A1 (en)	2014-09-11
US20130261153A1 (en)	2013-10-03
SI2833884T1 (sl)	2020-10-30
JP2018080183A (ja)	2018-05-24
CN110384699A (zh)	2019-10-29
KR20220132012A (ko)	2022-09-29
CL2014002523A1 (es)	2015-01-23
DK2833884T3 (da)	2020-08-10
KR20140144200A (ko)	2014-12-18
PT2833884T (pt)	2020-08-26
PH12014502239A1 (en)	2014-12-15
BR112014023795A8 (pt)	2017-10-10
EA201401083A1 (ru)	2015-03-31
ZA201406082B (en)	2019-01-30
WO2013149986A1 (en)	2013-10-10
EP4389217A2 (en)	2024-06-26
KR20210063481A (ko)	2021-06-01
US20160081998A1 (en)	2016-03-24
HUE051648T2 (hu)	2021-03-29
EA032263B1 (ru)	2019-05-31
HRP20201165T1 (hr)	2020-12-11
BR112014023795B1 (pt)	2021-09-08
MX2014011786A (es)	2014-12-05
JP2015512432A (ja)	2015-04-27
CY1123222T1 (el)	2021-10-29
CA2869269A1 (en)	2013-10-10
AU2013245027B2 (en)	2017-10-12
US20150099783A1 (en)	2015-04-09
RS60665B1 (sr)	2020-09-30

Publication	Publication Date	Title
IN2014DN06989A (es)	2015-04-10
EA201391486A1 (ru)	2014-09-30	Способы и композиции для лечения болезни паркинсона
EA201990019A1 (ru)	2019-05-31	Соединения и композиции для подавления активности shp2
EA201591727A1 (ru)	2016-05-31	Соединения биариламида в качестве ингибиторов киназы
AR099489A1 (es)	2016-07-27	2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
EA201391230A1 (ru)	2014-01-30	Соединения и композиции в качестве ингибиторов trk
EA201590581A1 (ru)	2015-07-30	Соединения бис-(фторалкил)-1,4-бензодиазепинона и их пролекарства
PH12014502866A1 (en)	2015-02-23	Fungicidal heterocyclic carboxamides
EA201290952A1 (ru)	2013-04-30	Химические соединения
AR090292A1 (es)	2014-11-05	Compuestos basados en pirazolo[1,5-a]pirimidina, composiciones que los comprenden y metodos que los utilizan
EA201590930A1 (ru)	2015-08-31	Лекарственные формы руксолитиниба с замедленным высвобождением
EA201590358A1 (ru)	2015-05-29	Ингибиторы репликации вируса иммунодефицита человека
EA201490103A1 (ru)	2014-06-30	Гидроксиметиларилзамещенные пирролотриазины в качестве ингибиторов alk1
AR089768A1 (es)	2014-09-17	Compuestos terapeuticamente activos y sus metodos de uso
BR112014009717A8 (pt)	2018-01-16	derivados de 2-(fenil ou pirid-3-il)aminopirimidina como moduladores de cinase lrrk2 para o tratamento de doença de parkinson.
PH12014501417A1 (en)	2014-09-22	Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
EA201790599A1 (ru)	2017-06-30	Соединения и композиции в качестве ингибиторов киназ
NZ703989A (en)	2017-04-28	Alkoxy pyrazoles as soluble guanylate cyclase activators
MD20150075A2 (ro)	2016-02-29	Compuşi tetraciclici heterociclu-substituiţi şi metode de utilizare a acestora pentru tratamentul bolilor virale
MY167898A (en)	2018-09-26	Co-crystals and salts of ccr3-inhibitors
BR112014010401A8 (pt)	2017-12-19	Inibidores do vírus da hepatite c rod-like que contêm o fragmento {2-[4-(bifenil-4-il)-1h-imidazo-2-il] pirrolidina-1-carbonilmetil}amina
IN2014DN07082A (es)	2015-04-10
PE20151718A1 (es)	2015-11-22	Compuestos piridinilpirazoloquinolina
MX348024B (es)	2017-05-24	Compuestos de adamantilo.
AR097894A1 (es)	2016-04-20	Inhibidores terapéuticos de cdk8 o uso de los mismos